期刊文献+

《医院处方集》的编写及其临床应用意义 被引量:1

Compilation and clinical applications of hospital formulary
下载PDF
导出
摘要 目的:总结本院《医院处方集》的编写思路和过程,阐述《医院处方集》在本院临床指导的意义。方法:回顾《医院处方集》的编写过程,进行总结分析。结果与结论:《医院处方集》分为总论、各论、附录、索引4个部分,具有妇产科用药的专业性、代表性和指导性。《医院处方集》在指导本院临床用药规范化上起到了积极的作用,同时可提高本院的诊疗水平,保障本院用药安全。 Objective: To summarize the compiling process of the hospital formulary and to analyze its clinical guiding siguifi-cance in Tianjin Central hospital of Gynecology Obstetrics. Methods: Processes of compiling the formulary are reviewed and ana- lyzed. Results and Conclusion: The hospital formulary includes four parts: general part, special part, appendix and index. The compendia improves greatly the standardization, quality and safety of medication in our hospital for it~ specific, representative and guiding property.
作者 刘梅
出处 《天津药学》 2012年第4期48-50,共3页 Tianjin Pharmacy
关键词 医院处方集 临床意义 合理用药 hospital formulary, clinical significance, rational drug applications
  • 相关文献

参考文献3

二级参考文献16

  • 1FIJIN R, LENDERINK A W, EQBERTS A C, et al. Assessment of indicators for hospital drug formulary non-adherence [ J ]. Eur J Clin Pharmacol, 2001,57(9) :677 -684.
  • 2RUTTIMANN S, KECK B, HARTMEIER C, et al. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital[ J ]. Clin Infect Dis, 2004 38 ( 3 ) : 348 - 356.
  • 3LEHUNANN D F, GUHARO Y, PAGE N, et al. Formulary management as a tool to improve medication use and gain physician support [J].Am JHealth Syst Pharm, 2007, 64(5) :464 -466.
  • 4SMETANA G W, DAVIS R B, PHILLIPS R S. Factors that influence patient response to requests to change to a unified restrictive formulary [J].J Gen Intern Med, 2004, 19(12) :1212 -1219.
  • 5OLSON B M. Approaches to pharmacy benefit management and the impact of consumer cost sharing [ J ]. Clin Ther, 2003, 25 ( 1 ) :250 - 272.
  • 6HASLE-PHAM E, AENOULD B, SPATH H M, et al. Role of clinical, patient-reported outcome and medico-economic studies in the public hospital drug formulary decision-making process: results of a European survey [ J ]. Health Policy, 2005, 71 ( 2 ) :205 - 212.
  • 7Holloway KA, Gautam BR, Reeves BC.The effects of diffe rent kinds of user fee on prescribing quality in rural Nepal[J]. Journal of Clinical Epidemiology, 2008, 54 (10) : 1 065.
  • 8Humphreys BD, Atkins MB.Rapid development of hypertension by sorafenib: toxicity or target?[J]. Clin Cancer Res. 2009.15 ( 19 ): 5 947.
  • 9Maitland ML, Kasza KE, Karrison T, et al.Ambulatory monitoring detects sorafenib induced blood pressure elevations on the first day of treatment[J]. Clin Cancer Res, 2009,15(19) : 6 250.
  • 10Strumbergd, Awada A, Herteh, et al. Pooled safety analysis of sorafenib monotherapy in patients with advanced solid tumours: is rash treatment outcome?[J]. Eur J Cancer, 2006,42 (4) : 548.

共引文献21

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部